RARP Surgical Volume Has No Effect on Quality of Life
Study compared surgeons who performed fewer than 100 robot-assisted radical prostatectomies with those who performed 100 or more.
AUA 2014 Prostate Cancer
Maximal Tumor Diameter Predicts PSA Failure Risk
This parameter can identify prostate cancer patients for whom adjuvant radiation therapy after radical prostatectomy may be of no benefit.
Fluoroquinolone Resistance Ups Post-Biopsy Infection Risk
Detecting fluoroquinolone-resistant organisms may allow for targeted antibiotic prophylaxis and identification of men at risk for infection.
Salvage Prostate Surgery Effective for Some Men
Patients should be selected carefully because of a higher incidence of locally advanced disease and regional lymph node metastases.
Post-Brachytherapy PSA Bounce Linked to Sexual Activity
PSA bounce was associated with significantly higher scores on the International Index of Erectile Function-15 questionnaire.
Minimum 15-Year Follow-Up After PCa Treatment Suggested
Study reveals a late recurrence rate of 3% and 5% at 15 and 20 years, respectively, after radiotherapy.
Prostate Cancer Treatment Incurs Long-Term Adverse Effects
In a study, 84% of men treated with radical surgery or radiation had erectile dysfunction after a median 11 years after their PCa diagnosis.
Drug Improves Outcomes in Chemotherapy-Naïve mCRPC Patients
Enzalutamide decreases the risk of radiographic progression and death compared with placebo in men not previously treated with docetaxel.
Low-Risk PCa Diagnosed on Repeat Biopsy More Favorable
Patients are less likely to have Gleason upgrading and extracapsular extension.
MRI/US Fusion Prostate Biopsy Predicts Final Pathology Better
It has lower pathologic upgrade rates at radical prostatectomy compared with standard 12-core biopsy.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in AUA 2014 Prostate Cancer
Loading... 
Loading...